Cargando…
Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo
Non-small cell lung cancer (NSCLC) and mesothelioma are renowned for being diagnosed at a late stage and poor prognosis. Although surgery, chemotherapy, and radiotherapy have yielded successful outcomes, the improvement on the survival rate of NSCLC and mesothelioma have been less marked. Recently,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307389/ https://www.ncbi.nlm.nih.gov/pubmed/30651858 http://dx.doi.org/10.3892/etm.2018.7015 |